Modafinil: A Review of Neurochemical Actions and Effects on Cognition
The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide, Provigil) is an FDA-approved medication with wake-promoting properties. Pre-clinical studies of modafinil suggest a complex profile of neurochemical and behavioral effects, distinct from those of amphetamine. In addition, modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention-deficit/hyperactivity disorder, and schizophrenia. Cognitive dysfunction may be a particularly important emerging treatment target for modafinil, across these and other neuropsychiatric disorders. We aimed to comprehensively review the empirical literature on neurochemical actions of modafinil, and effects on cognition in animal models, healthy adult humans, and clinical populations. We searched PubMed with the search term 'modafinil' and reviewed all English-language articles for neurochemical, neurophysiological, cognitive, or information-processing experimental measures. We additionally summarized the pharmacokinetic profile of modafinil and clinical efficacy in psychiatric patients. Modafinil exhibits robust effects on catecholamines, serotonin, glutamate, gamma amino-butyric acid, orexin, and histamine systems in the brain. Many of these effects may be secondary to catecholamine effects, with some selectivity for cortical over subcortical sites of action. In addition, modafinil (at well-tolerated doses) improves function in several cognitive domains, including workin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, side effects of alpha agonists like guanfacine and clonidine include high prevalence of somnolence or sedating effects,168,169”
From Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome (2023) · cites this paper as [168]
In the citing paper
“Modafinil, which is approved by the US Food and Drug Administration for the treatment of narcolepsy and its associated daytime sleepiness [59], is a logical candidate to address the hypoactive/sleepy aspects of CDS.”
Citations
Cites
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472 · cited 7×
“Importantly, modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described in the Aston…”
BackgroundMethodResultInfluentialNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 3×
“m Fos in orexin neurons in perfornical area 150 mg/kg i.p. Immunohisto-chemistry Mice Chemelli et al, 1999 75 mg/kg i.p. Immunohisto-chemistry Rat Scammell et al, 2000 No binding to orexin-1 receptor IC50 410mM 125I-human-orexin B displacement Transfected Chinese Hamster Ovary cells Wieland et al,…”
BackgroundAston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 1×
“It appears also that when levels of tonic LC activity are minimal, such as during sleep, grooming, and eating, that phasic responses are also less robust (Aston-Jones and Bloom, 1981).”
BackgroundTask-evoked pupillary responses, processing load, and the structure of processing resources.
Beatty, J. (1982) · Psychological Bulletin · doi:10.1037/0033-2909.91.2.276 · Cited by 1,959 · cited 1×
“…modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described…”
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592 · cited 15×
“Inhibition of DA cell firing in VTA/SN; blocked by Sulpiride 10mM but not by Prazosin 20 mM Extracellular recording Rat brain slice Korotkova et al, 2006 Hyperpolarization of VTA neurons, blocked by Sulpiride 10mM 20–50mM Whole-cell patch clamp Isolated VTA neurons No effect on mesencephalic DA neuron activity 128 mg/…”
BackgroundInfluentialDissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
The role of histamine and the tuberomamillary nucleus in the nervous system
Haas, H., & Panula, P. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1034 · Cited by 929 · cited 5×
“Thalamic NET occupancy: 16, 44% 5, 8 mg/kg i.v. PET with [11C]MeNER Rhesus monkey Madras et al, 2006 NET binding IC50¼ 35.6mM [3H] NE Human Embryo Kidney No effect on pontine NE neuron activity 128 mg/kg i.p. Single-unit recording Rat (anesthetized) Akaoka et al, 1991 Extracellular NE: m in PFC, medial hypothalamus 12…”
BackgroundInfluentialDopaminergic Role in Stimulant-Induced Wakefulness
Wisor, J. P., Nishino, S., Sora, I., Uhl, G. H., Mignot, E., & Edgar, D. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01787.2001 · Cited by 769 · cited 7×
“…extracellular DA levels (measured by microdialysis) that are increased significantly in the rat prefrontal cortex (PFC) (de Saint Hilaire et al, 2001), and in the caudate nucleus of narcoleptic dogs (Wisor et al, 2001), although only minimally in the rat hypothalamus (de Saint Hilaire et al, 2001).”
BackgroundInfluentialThe role of locus coeruleus in the regulation of cognitive performance
Usher, M., Cohen, J. D., Servan-Schreiber, D., Rajkowski, J., & Aston-Jones, G. (1999) · Science · doi:10.1126/science.283.5401.549 · Cited by 715
Research works printed but not linked: 1
- Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC et al (1999b). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30–40. · DOI · Paper page
Cited by
Items 401–500 of 735
A mechanistic overview of approaches for the treatment of psychostimulant dependence
Jensen, K. L., Jensen, S. B., & Madsen, K. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.854176 · Cited by 14
Mayeli, A., Clancy, K. J., Sonnenschein, S. F., Sarpal, D. K., & Ferrarelli, F. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114926 · Cited by 13
Solriamfetol enhances wakefulness and improves cognition and anxiety in a murine model of OSA
Badran, M., Puech, C., Barrow, M. B., Runion, A. R., & Gozal, D. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.04.007 · Cited by 12
Jiang, N., Zhang, Y., Yao, C., Chen, F., Liu, Y., Chen, Y., Wang, Y., Choudhary, M. I., & Liu, X. (2023) · Life Sciences in Space Research · doi:10.1016/j.lssr.2023.04.001 · Cited by 12
Effects of Modafinil on Behavioral Learning and Hippocampal Synaptic Transmission in Rats
Yan, W.-W., Yao, L.-H., Chen, C., Wang, H.-X., Li, C.-H., Huang, J.-N., Xiao, P., & Liu, C.-Y. (2015) · International Neurourology Journal · doi:10.5213/inj.2015.19.4.220 · Cited by 9
“In addition to treating excessive daytime sleepiness, modafinil has been shown to enhance attention and working memory in sleep-deprived humans and rodents [5,6].”
BackgroundIdentification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking
Phillips, T. J., Mootz, J. R. K., & Reed, C. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.001 · Cited by 12
Spreitzer, I., Keife, J., Strasser, T., Kalaba, P., Lubec, J., Neuhaus, W., Lübec, G., Langer, T., Wackerlig, J., & Loryan, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316956 · Cited by 12
“It is a wake-promoting agent that was approved in 1998 by the United States Food and Drug Administration (FDA) for treating daytime sleepiness in shift work sleep disorder or narcolepsy and obstructive sleep apnea [16].”
BackgroundSayyed, M. E., Ahmed, S., & Attallah, K. M. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02103-y · Cited by 11
Kwek, P., & van den Buuse, M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.041 · Cited by 11
“Modafinil is an anti-narcolepsy drug widely used off-label and as a mild stimulant (Kumar, 2008; Minzenberg and Carter, 2008).”
BackgroundLin, J., Roussel, B., Gaspar, A., Zhao, Y., Hou, Y., Schmidt, M. H., Jouvet, A., & Jouvet, M. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.06.008 · Cited by 11
Sakai, N., & Nishino, S. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01328-2 · Cited by 11
Peters, M. S., Park, C. H. J., Turner, A., Guerin, A. A., & Kim, J. H. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100064 · Cited by 11
Nishino, S. (2008) · Springer eBooks · doi:10.1007/978-1-4419-0854-4_24 · Cited by 12
“hydroxylase [25–28] (see also [29] for a review).”
BackgroundInhibitory effects of modafinil on emotional memory in mice
Fernandes, H. A., Zanin, K. A., Patti, C. L., Wuo‐Silva, R., Carvalho, R. C., Fernandes‐Santos, L., Bittencourt, L., Tufik, S., & Frussa‐Filho, R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.058 · Cited by 11
“…may increase the release of catecholamines (dopamine and norepinephrine), serotonin and glutamate, thereby reducing the release of GABA in various brain regions, and activating hypothalamic neurons containing hypocretin/orexin neurons of the tuberomammillary nucleus (Minzemberg and Carter, 2008).”
Treatments and compositions for attention deficit hyperactivity disorder: a patent review
Molina‐Carballo, A., Checa-Ros, A., & Muñoz‐Hoyos, A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1182989 · Cited by 14
“Modafinil is a good candidate agent for the remediation of cognitive dysfunction in neuropsychiatric disorders.[11] Bupropion (Wellbutrin) is a dual action antidepressant that inhibits the reuptake of dopamine and norepinephrine [12]; comparable effectiveness to MPH has been demonstrated, but firm conclusions are diff…”
BackgroundResultDowling, G., Kavanagh, P. V., Talbot, B. N., O’Brien, J. E., Hessman, G., McLaughlin, G., Twamley, B., & Brandt, S. D. (2016) · Drug Testing and Analysis · doi:10.1002/dta.2142 · Cited by 11
Hussein, A. M., Aher, Y. D., Kalaba, P., Aher, N. Y., Dragačević, V., Radoman, B., Ilić, M., Leban, J. J., Beryozkina, T., Ahmed, A. B. M. A., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.023 · Cited by 12
“Minzenberg and Carter [9] reviewed neurochemical action and effects on cognition in rodents, healthy adults and across psychiatric disorders that are considered advantageous for cognitive processes.”
Nelson, J. M., Phillips, C. A., McKinley, R. A., McIntire, L. K., Goodyear, C., & Monforton, L. (2019) · Military Psychology · doi:10.1080/08995605.2019.1598217 · Cited by 11
“However, tradeoffs have been attributed with these interventions that can be harmful to the human body such as nausea, restlessness and irritability (Minzenberg & Carter, 2008; Nehlig, 2010).”
BackgroundEffect of acute modafinil ingestion on cognitive and physical performance following mental exertion
Rattray, B., Martin, K., Hewitt, A. W., Cooper, G. M., & MCDONALD, W. A. (2019) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2700 · Cited by 11
“Mechanistically, this could be through altering the neuromodulatory environment related to effort and motivationally based behaviour (e.g., see Minzenberg & Carter, 2008), consistent with enhancing cognitive control processes (e.g., see Chong et al., 2017; Esposito et al., 2013) as has been…”
BackgroundGhorbanzadeh, H., Mohebkhodaei, P., Nematizadeh, M., Rahimi, N., Rafeiean, M., Ghasemi, M., & Dehpour, A. R. (2021) · Neurological Research · doi:10.1080/01616412.2021.1992102 · Cited by 11
Yang, C., Yang, J., Tan, L., Tang, P., Pen, T., Gao, T., Liu, S., & Guo, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3784580 · Cited by 14
Minzenberg, M., Watrous, A. J., Yoon, J. H., La, C., Ursu, S., & Carter, C. S. (2010) · Science · doi:10.1126/science.1177948 · Cited by 11
Self-citationThe dopaminergic dilema: Sleep or wake? Implications in Parkinson's disease
Lima, M. M. S., Reksidler, A. B., & Vital, M. A. B. F. (2008) · Bioscience hypotheses · doi:10.1016/j.bihy.2008.01.010 · Cited by 14
Vas, S., Casey, J. M., Schneider, W. T., Kalmár, L., & Morton, A. J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00849-y · Cited by 13
Cruces-Solís, H., Nissen, W., Ferger, B., & Arban, R. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108246 · Cited by 12
Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil
Cocco, E. E., & Fadda, P. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113906 · Cited by 11
Hosny, N. M., Gadallah, M. I., & Darwısh, I. A. (2023) · Analytical Methods · doi:10.1039/d3ay01401k · Cited by 10
Coppler, P. J., Gagnon, D. J., Flickinger, K. L., Elmer, J., Callaway, C. W., Guyette, F. X., Doshi, A. A., Steinberg, A., Dezfulian, C., Moskowitz, A. L., et al. (2024) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.23.158 · Cited by 10
“Modafanil promotes awakening through multiple proposed mechanisms including increasing dopamine, norepinephrine, serotonin transmission, and reducing extracellular γ - aminobutyric acid [25], but to our knowledge, no preclinical mechanistic evidence is available in cardiac arrest.”
BackgroundKamal, M.-A. M., Essam, R. M., Abdelkader, N. F., & Zaki, H. F. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10194-6 · Cited by 12
“Herein, the immunomodulating effect of MOD is revealed via indirect modulation of histamine along with subsequent attenuation of microglia activation as manifested by low Iba-1 immune expression, as previously mentioned (Minzenberg and Carter 2008; Zager 2020).”
A multi-pronged investigation of option generation using depression, PET and modafinil
Ang, Y.-S., Cusin, C., Petibon, Y., Dillon, D. G., Breiger, M., Belleau, E. L., Normandin, M. D., Schroder, H. S., Boyden, S., Hayden, E. R., et al. (2022) · Brain · doi:10.1093/brain/awab429 · Cited by 12
Shehata, S. A., Kolieb, E., Ali, D. A., Maher, S. A., Korayem, H. E., Ibrahim, M. A., Nafie, M. S., & Ameen, S. H. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-31093-4 · Cited by 10
“Although its mechanism of action is poorly understood, it was found to control numerous central nervous system transmitters, including glutamate, DA, 5-HT, NE, orexin, and GABA systems in the brain (Minzenberg and Carter 2008).”
Kardani, F., Khezeli, T., Rashedinia, M., Hashemi, M. B., jelyani, A. Z., Shariati, S., Mahdavinia, M., & Noori, S. M. A. (2024) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2024.106977 · Cited by 10
Modafinil augments oscillatory power in middle frequencies during rule selection
Minzenberg, M., Gomes, G. C., Yoon, J. H., Watrous, A. J., Geng, J. J., Firl, A. J., & Carter, C. S. (2014) · Psychophysiology · doi:10.1111/psyp.12201 · Cited by 10
“Catecholamine transport inhibitors such as amphetamine, methylphenidate, and modafinil not only enhance cognition in healthy individuals under certain conditions, but also remediate cognitive deficits in various clinical populations (Minzenberg, 2012; Minzenberg & Carter, 2008).”
BackgroundSelf-citationA Match Made by Modafinil: Probability Matching in Choice Decisions and Spatial Attention
Geng, J. J., Soosman, S. K., Sun, Y., DiQuattro, N. E., Stankevich, B. A., & Minzenberg, M. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00333 · Cited by 13
Self-citationClinical and neurocognitive changes with modafinil in obsessive–compulsive disorder: a case report
Dittrich, W. H., Johansen, T., Padhi, A. K., Smith, I. E., Chamberlain, S. R., & Fineberg, N. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1958-9 · Cited by 11
“The mechanisms by which modafinil modulates clinical and neurocognitive indices have yet to be clearly delineated (Minzenberg and Carter 2008).”
BackgroundInfluentialAge-dependent effects of modafinil on acoustic startle and prepulse inhibition in rats
McFadden, S. L., Zulas, A. L., & Morgan, R. E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.11.016 · Cited by 10
“In general, modafinil has been shown to increase alertness and improve cognitive abilities (learning, memory, and attention) in diverse clinical populations, including patients with schizophrenia, attention deficit hyperactivity disorder, and depression [2,39].”
BackgroundGupta, R., Gupta, L. K., & Bhattacharya, S. K. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.04.035 · Cited by 10
Reina, M., Celaya, C. A., & Muñiz, J. (2021) · ChemistrySelect · doi:10.1002/slct.202101227 · Cited by 12
Use of modafinil in patients with epilepsy
Artsy, E., McCarthy, D. C., Hurwitz, S., Pavlova, M. K., Dworetzky, B. A., & Lee, J. W. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.02.011 · Cited by 12
“Other postulated mechanisms of modafinil include an increase in serotonin and glutamine release and decreased GABA release [6].”
BackgroundQuisenberry, A. J., Prisinzano, T. E., & Baker, L. E. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.011 · Cited by 10
Arias-Carrión, Ó., Palomero‐Rivero, M., Millán‐Aldaco, D., Haro, R., Drucker-Colín, R., & Murillo‐Rodríguez, E. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.02.020 · Cited by 12
“, 2003), and dopaminergic (Minzenberg and Carter, 2008; Murillo-Rodríguez et al., 2008) system.”
Fox, K. C. R., Fitz, N. S., & Reiner, P. B. (2016) · Neuroethics · doi:10.1007/s12152-016-9282-7 · Cited by 12
“Conversely, enhancement drugs targeting other brain areas or neurotransmitter systems, such as *** Article in press at Neuroethics *** 20 modafinil (Minzenberg & Carter, 2008; Repantis, Schlattmann, Laisney, & Heuser, 2010) may be much less liable to such problems.”
BackgroundKumar, M., & Maqbool, S. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.02.014 · Cited by 10
Counterfeit formulations: analytical perspective on anorectics
Bonsu, D. O. M., Afoakwah, C., & Aguilar-Caballos, M. (2021) · Forensic Toxicology · doi:10.1007/s11419-020-00564-5 · Cited by 7
Regnier, S. D., Lile, J. A., Rush, C. R., & Stoops, W. W. (2022) · Journal of the Experimental Analysis of Behavior · doi:10.1002/jeab.744 · Cited by 10
Behandlung kognitiver Defizite bei Schizophrenie: Teil II: Pharmakologische Strategien
Roesch-Ely, D., Pfueller, U., Mundt, C., Müller, U., & Weisbrod, M. (2010) · Der Nervenarzt · doi:10.1007/s00115-009-2919-6 · Cited by 11
Minzenberg, M., Yoon, J. H., Soosman, S. K., & Carter, C. S. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0104-z · Cited by 10
Self-citationUsing caffeine as a chemical means to induce flow states
Reich, N., Mannino, M., & Kotler, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105577 · Cited by 9
“Furthermore, dopamine-elevating drugs, such as modafinil, are clinically approved treatments for day-time sleepiness in e.g. Parkinson ’ s disease (PD) and narcolepsy (Hogl et al., 2002; Minzenberg and Carter, 2008).”
Pharmacological cognitive enhancers
Peltier, M. R., & Sofuoglu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00023-x · Cited by 10
Xu, P., Huang, X., Niu, W., Yu, D., Zhou, M., & Wang, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.03.005 · Cited by 9
“Normal GABA transmission was crucial for the formation of cognition and target for drug (Minzenberg and Carter, 2008).”
BackgroundDiagnosing and treating hypersomnolence in depression
Moderie, C., & Boivin, D. B. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.10.008 · Cited by 10
Ranjbari, E., Philipsen, M. H., Wang, Z., & Ewing, A. G. (2021) · QRB Discovery · doi:10.1017/qrd.2021.4 · Cited by 11
“So far, most studies have been done at extracellular localised sites of action for modafinil in the brain (Keating and Raffin, 2005; Gerrard and Malcolm, 2007; Minzenberg and Carter, 2008).”
BackgroundInfluentialDifferential effects of wake promoting drug modafinil in aversive learning paradigms
Shanmugasundaram, B., Korz, V., Fendt, M., Braun, K., & Lübec, G. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00220 · Cited by 11
“Frontiers in Behavioral Neuroscience | www.frontiersin.org 1 August 2015 | Volume 9 | Article 220 and accuracy, support the evidence of cognitive enhancing effects (Minzenberg and Carter, 2008).”
InfluentialFixed drug eruptions with modafinil
Ghoshal, L., & Sinha, M. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.153437 · Cited by 9
“[9] It probably promotes wakefulness by increasing the level of glutamate, serotonin, and histamine; there is also evidence of the decrease of gamma amino butyric acid in the brain.[10] Modafinil has been tried in the treatment of diseases like attention deficit disorder, Alzheimer’s disease, idiopathic hypersomnia, c…”
BackgroundAstenia en cáncer avanzado y uso de psicoestimulantes
Portela, M. A., Rubiales, Á. S., Martínez, M., & Centeno, C. (2011) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272011000300013 · Cited by 14
Augmented Reality as a Countermeasure for Sleep Deprivation
Baumeister, J., Dorrian, J., Banks, S., Chatburn, A., Smith, R., Carskadon, M. A., Lushington, K., & Thomas, B. H. (2016) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2016.2518133 · Cited by 10
“Existing countermeasures are primarily caffeine and pharmaceutical stimulants [10, 31, 38], napping [32], exercise [17, 45], breaks [13], and environmental manipulation [4, 6].”
BackgroundHeyer-Osorno, R., & Juárez, J. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172936 · Cited by 9
Lubec, J., Hussein, A. M., Kalaba, P., Feyissa, D. D., Arias‐Sandoval, E., Cybulska-Kłosowicz, A., Bezu, M., Stojanovic, T., Korz, V., Maliković, J., et al. (2023) · Biomolecules · doi:10.3390/biom13030467 · Cited by 10
Acting Before; A Combined Strategy to Counteract the Onset and Progression of Dementia
Pizzi, S. D., Granzotto, A., Bomba, M., Frazzini, V., ONOFRJ, M. C., & Sensi, S. L. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201203085524 · Cited by 10
Wagener, N., Lehmann, W., Weiser, L., Jäckle, K., Fazio, P. D., Schilling, A. F., & Böker, K. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810257 · Cited by 8
Simulating a vigilance task: Extensible technology for baggage security assessment and training
Hubal, R. C., Mitroff, S. R., & Cain, M. S. (2010) · IEEE Conference on Technologies for Homeland Security (HST) · doi:10.1109/ths.2010.5654982 · Cited by 8
“, [16]) and recent noninvasive neurotechnologies (e.”
Hokmabad, R. V., Ziaee, M., Sadigh‐Eteghad, S., Shotorbani, S. S., & Mahmoudi, J. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.043 · Cited by 8
Modafinil in Forensic and Clinical Toxicology—Case Reports, Analytics and Literature
Radünz, L., Reuter, H., & Andresen‐Streichert, H. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky008 · Cited by 8
The Influence of Sports on Cognitive Task Performance – A Critical Overview
Dietz, P. (2013) · Trends in augmentation of human performance · doi:10.1007/978-94-007-6253-4_7 · Cited by 9
“The effects of such substances on cognitive task performance are mainly dependent on dosage and timing of intake (Caldwell et al. 2000; Wesensten et al. 2005; Minzenberg and Carter 2008; Repantis et al. 2009; Tye et al. 2010).”
BackgroundZager, A., Brandão, W. N., Margatho, R. O., da Cruz, D. S. G., Peron, J. P. S., Tufik, S. B., Andersen, M. L., Moresco, M., Pizza, F., Plazzi, G., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.009 · Cited by 8
“The D1 and D2 dopamine receptors, as well as the α-1 adrenergic receptor, are essential for mediating the effect of Modafinil on cognition and arousal (Minzenberg and Carter, 2008; Stone et al., 2002).”
MODAFINIL INTOXICATION INDUCED PERSISTENT PSYCHOSIS: CASE REPORT
Şahan, E., & Bolukbasi, O. (2019) · Psychiatria Danubina · doi:10.24869/psyd.2019.369 · Cited by 8
“It is known that modafinil increase extracellular dopamine, norepinephrine and serotonin concentrations in the neocortex (Minzenberg & Carter 2008).”
BackgroundInfluence of modafinil on early ejaculation – Results from a double-blind randomized clinical trial
Haghighi, M., Jahangard, L., Meybodi, A. M., Shayganfard, M., Ahmadpanah, M., Faryadres, M., Dürsteler, K. M., Brühl, A. B., Bahmani, D. S., & Brand, S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.015 · Cited by 9
A questionnaire study investigating future pharmacists’ use of, and views on cognitive enhancers
Hanna, L., Rainey, J., & Hall, M. (2018) · Research Portal (Queen's University Belfast) · Cited by 9
Enhancing cognition: The power of neuroplasticity
Mukhtar, I., & Iftikhar, K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102882 · Cited by 7
Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study
Chin, W., Huang, Y., Lam, N. Y. T., Mak, K. Y., Tang, I., Wang, C.-H., & Lin, C. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.04.024 · Cited by 8
Zhong, X., Xu, L., Wang, L., Chen, J., Gong, X., Lian, J., Gong, J., & Shao, Y. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.08.007 · Cited by 8
Nowak, K., Chłopaś‐Konowałek, A., Szpot, P., & Zawadzki, M. (2025) · Journal of Xenobiotics · doi:10.3390/jox15010015 · Cited by 7
An analytical review on probable anti-parkinsonian effect of modafinil
Farhoudi, M., Sadigh‐Eteghad, S., Andalib, S., Vafaee, M. S., Ziaee, M., & Mahmoudi, J. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.5681/jarcm.2013.008 · Cited by 7
Pharmacological compounds targeting emotional cognition in alcohol use disorder: A systematic review
Mistarz, N. T., Andersen, K., Nielsen, A. S., Goudriaan, A. E., Michel, T. M., Skøt, L., Anhøj, S. J., & Mellentin, A. I. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110535 · Cited by 8
How hypocretin agonists may improve the quality of wake in narcolepsy
Justinussen, J. L., Egebjerg, C., & Kornum, B. R. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.10.008 · Cited by 8
Lipschitz, J. M., Pérez-Rodríguez, M. M., Majd, M., Larsen, E. M., Locascio, J. J., Pike, C. K., Shanahan, M. R., & Burdick, K. E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1246149 · Cited by 7
“Finally, modafinil exhibits robust effects on various neurotransmitter systems in the brain, including catecholamines, serotonin, glutamate, gamma-aminobutyric acid (GABA), orexin, and histamine (16).”
BackgroundTreatment resistant depression
Vaccarino, S. R., & Kennedy, S. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821033-8.00003-4 · Cited by 8
Wu, K., Guo, T., Deng, C., Guan, Z., Li, L., Zhou, T., & Lu, W. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.124 · Cited by 7
Modafinil Effects on Middle-Frequency Oscillatory Power During Rule Selection in Schizophrenia
Minzenberg, M., Yoon, J. H., Cheng, Y., & Carter, C. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.155 · Cited by 8
“Modafinil shares many cellular and clinical effects with classic stimulants, which remediate cognition in patients with attention-deficit disorder on a dose-by-dose basis (see review in Minzenberg and Carter, 2008a).”
BackgroundSelf-citationDépendance aux drogues : avancées de la neurobiologie et perspectives thérapeutiques
Marie, N., & Noble, F. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.07.023 · Cited by 10
Developing Treatments for Stimulant Abuse: A Brief Overview.
Davidson, C. (2016) · PubMed · Cited by 9
Kinslow, C. J., Shapiro, S. D., Grunebaum, M. F., & Miller, E. C. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.07.023 · Cited by 7
“Alternatively, the combined serotoninergic effects of the two drugs[1, 2] may have precipitated RCVS.”
BackgroundMuili, A. O., Temilola, A. V., Oyekunle, O. I., Olajide, O. A., Conteh, D. N., & Kuol, P. P. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003442 · Cited by 6
“…deficit hyperactivity disorder, Alzheimer’s disease, and other related cognitive disorders have been effective in enhancing cognitive function [ 6 , 9-11 Likewise, improvement in the academic, and professional achievement or performance of individuals has been associated with the use of agents…”
Dose-dependent subacute cardiovascular effects of modafinil in rats
Canyurt, D., Tanrıverdi, L. H., Özhan, O., Cansel, M., Parlakpınar, H., Vardı, N., Çiğremiş, Y., Yıldız, A., Karaca, Y., Yaşar, Ş., et al. (2020) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1803906 · Cited by 6
Repurposing of modafinil as an anti-inflammatory drug: a systematic review of experimental studies
Amini, M. J., Seighali, N., Bahri, R. A., Ala, M., Jafari, R. M., & Dehpour, A. R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03964-9 · Cited by 6
“The IC50 for modafinil ranges from 3.2 to 4.0 μM based on the literature (Minzenberg and Carter 2008; Wisor 2013; Volkow et al. 2009), suggesting that although modafinil affects dopamine levels, its potency is lower than other stimulants.”
InfluentialHosny, N. M., Gadallah, M. I., Gomila, R. M., & Qayed, W. S. (2021) · Talanta · doi:10.1016/j.talanta.2021.122890 · Cited by 6
Error-related Alpha Suppression: Scalp Topography and (Lack of) Modulation by Modafinil
Schroder, H. S., Iturra-Mena, A. M., Breiger, M., Linton, S. R., Robble, M. A., Kangas, B. D., Bergman, J., Nickels, S., Vitaliano, G. D., Der‐Avakian, A., et al. (2022) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_01836 · Cited by 6
“Interestingly, modafinil—primarily considered a dopamine reuptake inhibitor (Volkow et al., 2009)—also occupies NE transporter sites (Minzenberg & Carter, 2008; Madras et al., 2006) and directly shifts NE output of the LC (Minzenberg et al., 2010).”
BackgroundModafinil does not reduce cocaine use in methadone-maintained individuals
DeVito, E. E., Poling, J. C., Babuscio, T. A., Nich, C., Carroll, K. M., & Sofuoglu, M. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100032 · Cited by 7
Pizzi, S. D., Tomaiuolo, F., Ferretti, A., Bubbico, G., Onofrj, V., Penna, S. D., Sestieri, C., & Sensi, S. L. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.11.010 · Cited by 11
Modafinil alters the functional connectivity of distinct thalamic nuclei with the neocortex
Pizzi, S. D., Tomaiuolo, F., Sestieri, C., Chiarelli, A. M., Gambi, F., Ferretti, A., & Sensi, S. L. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121242 · Cited by 8
“First, we administered a 100 mg dosage of modafinil, which is below the typical therapeutic range (200 – 400 mg; Minzenberg et al., 2008; Li et al., 2020; Schmidt et al., 2017), to limit eventual side effects, especially in the elderly population.”
InfluentialNeuropsychology of Treatment-Resistant Schizophrenia
Woodward, N. D., & Meltzer, H. Y. (2010) · Advances in biological psychiatry · doi:10.1159/000319807 · Cited by 6
Cognitive Enhancement in Humans
Dresler, M., & Repantis, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00011-5 · Cited by 7
Resistance to Propofol Induction in a Patient Taking Modafinil: A Case Report
Harwood, T. N. (2017) · A & A Case Reports · doi:10.1213/xaa.0000000000000606 · Cited by 6
“Multiple factors point to this determination: (1) in the brain, modafinil counteracts what likely are the mechanisms involved in the induction of sleep by propofol; (2) case reports indicate that the response to volatile anesthetics does not appear to be affected by modafinil; and (3) modafinil was the only CNS-alteri…”
BackgroundAdam, L. C., Repantis, D., Konrad, B. N., Dresler, M., & Kühn, S. (2021) · Brain and Cognition · doi:10.1016/j.bandc.2021.105802 · Cited by 8
“…time to reach Cmax (Tmax) for CAF = 60 min, for MPH = 90 - 190 min, and MOD = 120 – 240 min, 90 minutes was chosen as a reasonable average to reach Tmax of each substance (Dolder, Müller, Schmid, Borgwardt, & Liechti, 2017; Minzenberg & Carter, 2008; Swanson & Volkow, 2003; Volkow et al., 2015).”
BackgroundMethodEffects of modafinil on electroencephalographic microstates in healthy adults
Linton, S. R., Murphy, M., Schroder, H. S., Breiger, M., Iturra-Mena, A. M., Kangas, B. D., Bergman, J., Carlezon, W. A., Risbrough, V. B., Barnes, S. A., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06149-x · Cited by 6
High-Dose, Self-Administered Modafinil–Related Psychosis
Rudhran, V., Manjunatha, N., & John, J. P. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829465b1 · Cited by 6
Jung, J., Lee, Y., Son, J.-Y., Lim, E., Jung, M., & Oh, S. (2011) · Molecules · doi:10.3390/molecules161210409 · Cited by 6
Bibani, R. H., Tench, C. R., George, J., Manouchehrinia, A., Palace, J. A., & Constantinescu, C. S. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2012.03.004 · Cited by 7
Hyponatraemia and cerebral oedema due to a modafinil overdose
Kandasamy, R., Kaminskaite, V., & May, F. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-234530 · Cited by 6
Nishino, S., & Kotorii, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-23739-8_22 · Cited by 7
Metadata
- Authors
- Minzenberg, M. J., & Carter, C. S.
- Affiliations
- University of California Davis Medical Center (US)
- Corresponding author
- Minzenberg, Michael J
- Venue
- Neuropsychopharmacology
- Published
- 2007-08-22
- Volume
- 33
- Issue
- 7
- Pages
- 1477-1502
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2122011624
- Semantic Scholar
- cf5b2a15296e7832bcfdd965f28583772ef2999c
- Cited by
- 713
- References
- 215
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 25 · 2023: 33 · 2022: 33 · 2021: 46 · 2020: 26 · 2019: 19 · 2018: 33 · 2017: 42 · 2016: 22 · 2015: 49 · 2014: 48 · 2013: 62 · 2012: 59
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 59883, MH066629, R01MH059883, R01MH066629)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- modafinil, wakefulness-promoting agents, neurochemical mechanisms, cognition, catecholamines, serotonin, glutamate, GABA, orexin, histamine, working memory, episodic memory, prefrontal cortex, cognitive control, treatment-resistant depression, attention deficit hyperactivity disorder, schizophrenia, cognitive impairment, pharmacokinetics, abuse liability
- MeSH terms
- Modafinil, Animals, Mental Disorders, Benzhydryl Compounds, Brain Chemistry, Cognition, Humans, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.